Recommend to a friend

Switching Between Biologics: Is a Biosimilar an Option?

Upon completion of the activity, participants should be able to explain the circumstances under which it is appropriate to initiate or switch a patient with a dermatologic condition to a biosimilar.
IL-derm-case3